Interv Akut Kardiol. 2021;20(2):73-77 | DOI: 10.36290/kar.2021.023

Pathogenesis of covid-19: principles of viral infection and immune response

Jiří Beneš1, Dana Nováková2
1 Klinika infekčních nemocí 3. LF UK, Nemocnice Na Bulovce, Praha
2 Klinika nukleární medicíny a endokrinologie, FN Motol, Praha

SARS-CoV-2 infection manifests itself with several clinical forms, from an asymptomatic course to a life-threatening multiple-organ dysfunction. In terms of pathogenesis, these clinical forms can be divided into a group of mucosal infections (respiratory tract infections, gastroenteritis) and internal organ infections (especially pneumonia). Of particular concern is the dysregulated immune response associated with the production of proinflammatory cytokines (IL-1, IL-6, TNFα) which is otherwise typical of severe bacterial infections. Knowledge of the pathogenetic context allows for better interpretation of the virological and serological findings and aids in choosing an individualized covid-19 treatment.

Keywords: SARS-CoV-2, covid-19, immune response, pathogenesis.

Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beneš J, Nováková D. Pathogenesis of covid-19: principles of viral infection and immune response. Interv Akut Kardiol. 2021;20(2):73-77. doi: 10.36290/kar.2021.023.

Download citation

References

  1. Hikmet F, Méar L, Edvinsson Å, et al. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020; 16: e9610. Go to original source... Go to PubMed...
  2. Englund JA, Kim YJ, McIntosh K. Human coronaviruses, including MERS coronavirus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ (eds.): Feigin and Cherry´s Textbook of Pediatric Infectious Diseases. 8th ed. Philadelphia: Elsevier, 2019: 1846-1854.
  3. Hilleman MR. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc Natl Acad Sci U S A. 2004; 101(Suppl. 2): 14560-6. Go to original source... Go to PubMed...
  4. Kumar S, Nyodu R, Maurya VK, Saxena SK. Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection. In: S. K. Saxena (ed.), Coronavirus Disease 2019 (covid-19), Medical Virology: from Pathogenesis to Disease Control. Available at: https://doi.org/10.1007/978-981-15-4814-7_5. Go to original source...
  5. Klein S, Cortese M, Winter SL, et al. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun. 2020; 11(1): 5885. Go to original source... Go to PubMed...
  6. Snijder EJ, Limpens RWAL, de Wilde AH, et al. A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. PLoS Biol. 2020; 18(6): e3000715. Go to original source... Go to PubMed...
  7. Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al. Imbalanced host response to SARS-CoV-2 drives development of covid-19. Cell. 2020; 181(5): 1036-1045.e9. Go to original source... Go to PubMed...
  8. Li X, Geng M, Peng Y, et al. Molecular immune pathogenesis and diagnosis of covid-19. J Pharm Anal. 2020; 10(2): 102-108. Go to original source... Go to PubMed...
  9. Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020; 92(4): 424-432. Go to original source... Go to PubMed...
  10. Taefehshokr N, Taefehshokr S, Hemmat N, Heit B. Covid-19: Perspectives on innate immune evasion. Front Immunol. 2020; 11: 580641. Go to original source... Go to PubMed...
  11. Beneš J, Džupová O, Poláková A, Sojková N. Opakovaně negativní PCR u pacientů s projevy covid-19: Mají či nemají infekci SARS-CoV-2? Epidemiol Mikrobiol Imunol. 2021; 70(1): 3-9.
  12. Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020; 18(1): 206. Go to original source... Go to PubMed...
  13. Dhouib W, Maatoug J, Ayouni I, et al. The incubation period during the pandemic of covid-19: a systematic review and meta-analysis. Syst Rev. 2021; 10(1): 101. Go to original source... Go to PubMed...
  14. Quesada JA, López-Pineda A, Gil-Guillén VF, et al. Incubation period of covid-19: A systematic review and meta-analysis. Rev Clin Esp (Barc). 2021; 221(2): 109-117. Go to original source... Go to PubMed...
  15. Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to covid-19. Sci Immunol. 2020; 5(53): eabe8063. Go to original source... Go to PubMed...
  16. Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020; 20(6): 375-388. Go to original source... Go to PubMed...
  17. Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild covid-19. Cell. 2020; 183(1): 158-168.e14. Go to original source... Go to PubMed...
  18. Ward H, Cooke GS, Atchison C. Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults. Lancet Reg Health Eur. 2021; 4: 100098. Go to original source... Go to PubMed...
  19. Rodda LB, Netland J, Shehata L, et al. Functional SARS-CoV-2-specific immune memory persists after mild covid-19. Cell. 2021; 184(1): 169-183.e17. Go to original source... Go to PubMed...
  20. Agulló V, Fernández-González M, Ortiz de la Tabla V, et al. Evaluation of the rapid antigen test Panbio covid-19 in saliva and nasal swabs in a population-based point-of-care study. J Infect. 2021; 82(5): 186-230. Go to original source... Go to PubMed...
  21. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, et al. Novel coronavirus infection (covid-19) in humans: a scoping review and meta-analysis. J Clin Med. 2020; 9(4): E941. Go to original source... Go to PubMed...
  22. Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance United States, January 22 - May 30, 2020. Morb Mortal Wkly Rep 2020; 69(24): 759-765. Go to original source... Go to PubMed...
  23. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020; 17(9): e1003346. Go to original source... Go to PubMed...
  24. Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with covid-19. J Microbiol Immunol Infect. 2021; 54(1): 12-16. Go to original source... Go to PubMed...
  25. Parcha V, Booker KS, Kalra R, et al. A retrospective cohort study of 12,306 pediatric covid-19 patients in the United States. Sci Rep. 2021; 11: 10231. Go to original source... Go to PubMed...
  26. Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020; 369(6499): 50-54. Go to original source... Go to PubMed...
  27. Kakodkar P, Kaka N, Baig MN. A Comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (covid-19). Cureus. 2020; 12(4): e7560. Go to original source... Go to PubMed...
  28. Sinha P, Calfee CS, Cherian S, et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with covid-19: a prospective observational study. Lancet Respir Med 2020. https://doi.org/10.1016/S2213-2600(20)30366-0 [Epub ahead of print]. Go to original source... Go to PubMed...
  29. Ferda J, Mírka H, Baxa J, et al. Urgentní výpočetní tomografie při podezření na onemocnění covid-19. Ces Radiol, 2020; 74(1): 577-583.
  30. Hani C, Trieu NH, Saab I, et al. Covid-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020; 101(5): 263-268. Go to original source... Go to PubMed...
  31. Russell MW, Moldoveanu Z, Ogra PL, Mestecky J. Mucosal immunity in covid-19: a neglected but critical aspect of SARS-CoV-2 infection. Front Immunol. 2020; 11: 611337. Go to original source... Go to PubMed...
  32. Ceemed: informace viz http://ceemed.eu/project/sars-cov-2-antigen-quantitative-assay-kit/.
  33. Lin Q, Zhu L, Ni Z, et al. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection. J Microbiol Immunol Infect. 2020; 53(5): 821-822. Go to original source... Go to PubMed...
  34. Lui G, Ling L, Lai CKC, et al. Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in covid-19. Infect. 2020; 81(2): 318-56. Go to original source... Go to PubMed...
  35. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631-637. Go to original source... Go to PubMed...
  36. Hu B, Huang S, Yin L. The cytokine storm and covid-19. J Med Virol. 2021; 93(1): 250-256. Go to original source... Go to PubMed...
  37. Ragab D, Salah Eldin H, Taeimah M, et al. The covid-19 cytokine storm; what we know so far. Front Immunol. 2020; 11: 1446. Go to original source... Go to PubMed...
  38. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in covid-19. J Infection. 2020; 80(6): 606-613. Go to original source... Go to PubMed...
  39. Leisman, DE, Ronner, L, Pinotti, R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med 2020; 1620: 30404-5. Go to original source... Go to PubMed...
  40. Lippi G, Plebani M. Cytokine "storm", cytokine "breeze", or both in covid-19? Clin Chem Lab Med. 2020. doi: 10.1515/cclm-2020-1761. Epub ahead of print. Go to original source... Go to PubMed...
  41. Krejsek J, Kopecký O. Klinická imunologie. Hradec Králové: Nucleus HK, 2004.
  42. Jílek P. Imunologie stručně, jasně, přehledně. 2nd ed. Praha: Grada, 2019.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.